Literature DB >> 65590

Gentamicin persistence in the body.

J J Schentag, W J Jusko.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 65590     DOI： 10.1016/s0140-6736(77)91973-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Hypomagnesaemic tetany associated with prolonged treatment with aminoglycosides.

Authors:  C J Kelnar
Journal:  Br Med J (Clin Res Ed)       Date:  1986-04-12

Review 2.  Clinical relevance of pharmacokinetics.

Authors:  G Tognoni; C Bellantuono; M Bonati; M D'Incalci; M Gerna; R Latini; M Mandelli; M G Porro; E Riva
Journal:  Clin Pharmacokinet       Date:  1980 Mar-Apr       Impact factor: 6.447

Review 3.  Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.

Authors:  J E Jackson; R Bressler
Journal:  Drugs       Date:  1981-10       Impact factor: 9.546

4.  Gentamicin disposition and tissue accumulation on multiple dosing.

Authors:  J J Schentag; W J Jusko; J W Vance; T J Cumbo; E Abrutyn; M DeLattre; L M Gerbracht
Journal:  J Pharmacokinet Biopharm       Date:  1977-12

Review 5.  Combination therapy for treatment of infections with gram-negative bacteria.

Authors:  Pranita D Tamma; Sara E Cosgrove; Lisa L Maragakis
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

6.  Hypomagnesaemic hypocalcaemia with hypokalaemia caused by treatment with high dose gentamicin.

Authors:  C J Kelnar; W S Taor; D J Reynolds; D R Smith; B M Slavin; C G Brook
Journal:  Arch Dis Child       Date:  1978-10       Impact factor: 3.791
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.